An interventional study of Blood Flow Restriction Resistance Training (BFR-RT) and Sham Blood Flow Restriction in Achilles Tendon Rupture, Blood Flow Restriction Therapy and Achilles Tendon Repairs/Reconstructions, sponsored by Massachusetts General Hospital. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-04-01.
Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Tendon Injuries with a site in United States — 4 open to participants now, 7 under way, none of them phase 3. Tendon Injuries · United States.
Among the 23 studies in Tendon Injuries with a site in United States, this one is the 5th largest by planned enrollment of the 18 interventional ones that give a count, is one of 2 that started in 2026, is one of 13 with no phase, and was the 23rd registered.
101 studies on the registry are indexed under Tendon Injuries; 28 are open to participants now.
Browse Tendon Injuries studies →4 of the 23 studies in Tendon Injuries with a site in United States are open now. Recruiting first, the newest first:
Rocky Vista University, LLC · Sites in United States
Ages 18–40 · Healthy volunteers
NYU Langone Health · Sites in United States
Ages 18–65
Research Source · Sites in United States
Ages 18–90 · Healthy volunteers
Spaulding Rehabilitation Hospital · Sites in United States
Ages 18–65
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 12 Tendon Injuries studies recruiting now, 5 (42%) set no upper age limit and 7 (58%) stop at 75 or younger; 3 take children under 18; 2 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 75 is above the median of 44 across 71 interventional studies indexed under Tendon Injuries.
Median enrollment 28 across the 18 interventional studies, 100 across the 5 observational. Of the 13 that completed or were terminated, 3 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 23 have an industry lead sponsor. The 10 most frequent:
Massachusetts General Hospital is the lead sponsor of 2,591 studies on the registry; 445 are open to participants now.
Of its 224 completed or terminated interventional studies of FDA-regulated products, 168 (75%) have results posted.
Massachusetts General Hospital has 1 study filed under Tendon Injuries — fewer than ten, so there is no comparison to draw.
2 of the studies in Tendon Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05735119Zimmer BiometEmbody Post-Market Clinical Follow-Up Study | 2026-11 |
| NCT07498166Massachusetts General HospitalProject Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 23 studies in Tendon Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to determine whether blood flow restriction resistance training (BFR-RT) improves postoperative muscle recovery and functional outcomes following primary surgical repair of acute Achilles tendon rupture (ATR) in adults undergoing standard rehabilitation. The main questions it aims to answer are:
Does patient-specific BFR-RT improve ankle plantarflexion strength recovery compared with sham BFR-RT or standard rehabilitation alone?
Does BFR-RT improve gastrocnemius-soleus muscle morphology and patient-reported functional outcomes following ATR repair?
Researchers will compare (1) BFR-RT combined with standard physical therapy, (2) sham BFR-RT combined with standard physical therapy, and (3) standard physical therapy alone to determine whether BFR-RT enhances muscle recovery, functional outcomes, and return-to-activity timelines following surgical ATR repair.
Participants will:
Be randomized to BFR-RT + standard physical therapy, sham BFR-RT + standard physical therapy, or standard physical therapy alone
Perform supervised rehabilitation exercises using a personalized tourniquet system calibrated to limb occlusion pressure (LOP) depending on group allocation
Undergo isometric ankle plantarflexion strength testing using the Fysiometer platform
Receive ultrasound imaging of the gastrocnemius-soleus complex to assess muscle cross-sectional area
Complete patient-reported outcome measures assessing pain and physical function
Attend follow-up evaluations at 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively
Achilles tendon rupture (ATR) is a common musculoskeletal injury that frequently results in prolonged functional impairment despite successful surgical repair. Even with modern operative techniques and standardized rehabilitation protocols, many patients demonstrate persistent weakness of the gastrocnemius-soleus complex, deficits in ankle plantarflexion strength, and delayed return to activity. These deficits are thought to arise from a combination of postoperative immobilization, restricted early loading, and muscle atrophy during the early phases of recovery. Conventional postoperative rehabilitation protocols typically emphasize gradual progression of low-load resistance training to protect the healing tendon. While these protocols prioritize tendon safety, they may provide insufficient mechanical and metabolic stimulus to promote optimal muscle hypertrophy and neuromuscular recovery during the early postoperative period.
Blood flow restriction resistance training (BFR-RT) has emerged as a potential strategy to enhance muscular adaptation while using low mechanical loads. By applying controlled external pressure to the proximal limb during exercise, BFR-RT produces localized hypoxia and metabolic stress that can stimulate anabolic signaling pathways associated with muscle hypertrophy and strength gains. Prior studies in orthopedic and sports rehabilitation settings-including anterior cruciate ligament reconstruction and chronic Achilles tendinopathy-have demonstrated that low-load BFR-RT can produce physiologic adaptations comparable to traditional high-load resistance training while minimizing mechanical stress on healing tissues. However, the efficacy and safety of BFR-RT during the early rehabilitation period following primary ATR repair have not been evaluated in a prospective randomized clinical trial.
This study is designed as a prospective, three-arm randomized controlled trial to evaluate whether integrating BFR-RT into postoperative ATR rehabilitation improves early muscle recovery and functional outcomes while maintaining an acceptable safety profile. Participants undergoing primary surgical repair for an acute unilateral mid-portion ATR will be randomized to one of three rehabilitation protocols: BFR-RT combined with standard physical therapy, sham BFR-RT combined with standard physical therapy, or standard physical therapy alone. The BFR intervention will be delivered using a personalized tourniquet system that determines limb occlusion pressure for each participant to standardize vascular restriction and minimize inter-individual variability in occlusion levels.
Participants will undergo standardized postoperative rehabilitation and will be followed longitudinally over a 12-month recovery period. Clinical assessments will be performed at predefined postoperative intervals to evaluate physiologic recovery of the gastrocnemius-soleus complex and patient-centered functional outcomes. Safety monitoring will include systematic documentation of potential adverse events associated with postoperative rehabilitation or vascular restriction techniques.
By evaluating the physiologic and clinical effects of patient-specific BFR-RT following surgical ATR repair, this study aims to generate evidence regarding whether low-load metabolic training can safely accelerate muscle recovery and improve functional rehabilitation outcomes in this population. Findings from this trial may inform future postoperative rehabilitation protocols and help define the role of BFR-RT as an adjunctive strategy in tendon repair recovery pathways.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive standard postoperative Achilles tendon rehabilitation combined with blood flow restriction resistance training using the Delfi Personalized Tourniquet System. Cuffs are calibrated to 80% limb occlusion pressure to induce controlled vascular restriction during low-load resistance exercises. All sessions are supervised by trained physiotherapists following the standardized Massachusetts General Hospital Achilles rehabilitation protocol.
Device: Blood Flow Restriction Resistance Training (BFR-RT) · Behavioral: Standard Physical Therapy
Participants receive the same standardized postoperative rehabilitation protocol while wearing Delfi tourniquet cuffs inflated to 20 mmHg, a pressure insufficient to induce blood flow restriction. This sham condition controls for potential placebo effects associated with the device while maintaining identical exercise protocols and therapist supervision.
Device: Sham Blood Flow Restriction · Behavioral: Standard Physical Therapy
Participants undergo the standardized Massachusetts General Hospital postoperative Achilles tendon rehabilitation program including range-of-motion exercises, progressive strengthening, and return-to-sport phases. No blood flow restriction device is used during rehabilitation sessions.
Behavioral: Standard Physical Therapy
Blood flow restriction resistance training will be performed using the Delfi Personalized Tourniquet System applied to the affected limb during supervised rehabilitation exercises. The device automatically determines limb occlusion pressure (LOP) and applies 80% of LOP during low-load resistance exercises. This controlled vascular restriction produces metabolic stress intended to stimulate muscle hypertrophy and strength recovery while minimizing mechanical load on the healing Achilles tendon. Sessions are conducted under physiotherapist supervision within the standardized postoperative rehabilitation protocol.
Also known as: Delfi Personalized Tourniquet System
Participants assigned to the sham group will wear the Delfi tourniquet cuff during rehabilitation sessions; however, cuff pressure will be inflated only to 20 mmHg, a level insufficient to induce vascular occlusion. This condition mimics the experience of the intervention device while avoiding physiologic blood flow restriction, thereby controlling for potential placebo effects associated with device use.
Participants will undergo the standardized postoperative Achilles tendon rehabilitation program used at Massachusetts General Hospital. The protocol includes progressive weight-bearing, range-of-motion exercises, strengthening maneuvers, and return-to-sport progression phases supervised by trained physiotherapists.
Also known as: Standard Postoperative Achilles Rehabilitation Protocol
Achilles Tendon Total Rupture Score (ATRS)
The Achilles Tendon Total Rupture Score (ATRS) is a validated patient-reported outcome instrument used to assess symptoms and physical function following Achilles tendon rupture. The score ranges from 0 to 100, with higher scores indicating better function and fewer symptoms.
Time frame: 12 months postoperatively
Ankle Plantarflexion Isometric Strength (Limb Symmetry Index)
Isometric ankle plantarflexion strength will be measured using the Fysiometer platform. Results will be expressed as limb symmetry index (LSI), calculated as the ratio of injured limb strength to contralateral limb strength expressed as a percentage.
Time frame: 3 months, 4.5 months, 6 months, and 12 months postoperatively
Gastrocsoleus Muscle Cross-Sectional Area
Cross-sectional area of the gastrocnemius-soleus muscle complex measured using portable ultrasound imaging to quantify muscle morphology and recovery following Achilles tendon repair.
Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively
Visual Analog Scale (VAS) Pain Score
Pain intensity will be measured using a 10-point Visual Analog Scale (VAS), where 0 represents no pain and 10 represents the worst possible pain. Higher scores indicate greater pain severity.
Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively
Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Score
Pain interference will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference questionnaire. Scores are reported as T-scores with a mean of 50 and standard deviation of 10 in the general population; scores range from approximately 41 to 77, with higher scores indicating greater pain interference with daily activities.
Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively
Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Score
Physical function will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function questionnaire, which evaluates the participant's ability to perform physical activities. Scores are reported as T-scores with a mean of 50 and standard deviation of 10 in the general population; higher scores indicate better physical function.
Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively
Foot and Ankle Ability Measure (FAAM)
The Foot and Ankle Ability Measure (FAAM) is a validated patient-reported outcome instrument assessing functional limitations related to foot and ankle conditions. Scores range from 0 to 100, with higher scores indicating greater functional ability.
Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively
Single-Leg Heel Rise Test
Functional calf endurance will be evaluated using the single-leg heel rise test measuring the number of heel raises completed on the affected limb.
Time frame: 3 months, 4.5 months, 6 months, and 12 months postoperatively
Single-Leg Heel Rise Height
Heel rise height will be measured during the single-leg heel rise test to assess plantarflexion strength and functional calf performance.
Time frame: 3 months, 4.5 months, 6 months, and 12 months postoperatively
International Physical Activity Questionnaire - Short Form (IPAQ-SF)
Physical activity levels will be assessed using the International Physical Activity Questionnaire - Short Form (IPAQ-SF), which evaluates participant activity levels across multiple domains.
Time frame: 6 months and 12 months postoperatively
EQ-5D-5L Quality of Life Score
Health-related quality of life will be assessed using the EQ-5D-5L (EuroQol 5-Dimension 5-Level) questionnaire. The EQ-5D-5L index score ranges from 0 to 1, with higher scores indicating better health-related quality of life. A visual analogue scale (VAS) component ranges from 0 to 100, with higher scores indicating better self-rated health.
Time frame: 6 months and 12 months postoperatively
Ankle Range of Motion
Active and passive ankle plantarflexion and dorsiflexion range of motion will be measured bilaterally using a goniometer.
Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively
Calf Circumference
Bilateral calf circumference measurements will be obtained to assess muscle atrophy and recovery following Achilles tendon repair.
Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively
Return-to-Sport Status and Time
Participants will report return-to-sport status and time required to resume pre-injury sport or physical activity.
Time frame: Up to 12 months postoperatively
Plan to share: No — There are no current plans to share individual participant data. Data generated in this investigator-initiated study are subject to institutional data governance and participant privacy protections, and the study team has elected not to make IPD publicly available at this time.
Started Feb 2026 (actual). Primary completion is estimated for Dec 2026, 10 months after the start.
Of 37 non-industry interventional studies with no phase under Tendon Injuries, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 46. This study's planned 10 months is below that.
Counting every sponsor, half of 39 studies reached it within 14 months; a quarter within 7 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital →